GlassScriptPhysician profile
Keith S Hechtman
NPI 1942275201
$112,576.77
in general payments reported to CMS, 2019-2025
12 companies · $84.88 in 2025
The $84.88 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $70K · 2021: $16K · 2022: $408 · 2023: $182 · 2024: $652 · 2025: $84.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $895 · Travel and Lodging: $24.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $894.96 |
| Travel and Lodging | $24.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $71,356.81 | 2020-2024 | Inlay Glenoid 2.0, Glenojet, Ovo Motion |
| Zimmer Biomet Holdings, INC. | $35,553.83 | 2019-2020 | |
| Southern Edge Orthopaedics, INC. | $2,035.76 | 2020-2021 | |
| Arthrex, INC. | $1,216.00 | 2021 | |
| Arthrosurface Incorporated | $819.15 | 2019 | |
| Smith+Nephew, INC. | $653.82 | 2019-2025 | Ultrabutton, Spatial Frame, Pico 14 |
| Horizon Therapeutics Plc | $313.45 | 2019-2020 | |
| Vericel Corporation | $284.13 | 2019-2025 | Maci |
| Linvatec Corporation | $149.41 | 2022 | |
| Miach Orthopaedics, INC. | $112.78 | 2023 | |
| Depuy Synthes Sales INC. | $44.71 | 2024 | Truespan Orthocord |
| My01 INC. | $36.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$50,401.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Hechtman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.